MI
SBIO icon

Motiv8 Investments’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Motiv8 Investments’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3 Buy
+60
New +$2.77K ﹤0.01% 696

Other funds holding SBIO

PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
DIM
Delta Investment Management San Francisco, California $559M AUM 19.86% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Motiv8 Investments's SBIO Position: Q4 2025 in Review

Motiv8 Investments opened a new position in ALPS Medical Breakthroughs ETF (SBIO) in Q4 2025: 60 shares worth $3. The stake represents ﹤0.01% of the portfolio and ranks #696 among its holdings.

58 funds tracked by Wall St. Rank hold SBIO as of Q4 2025.

  • Motiv8 Investments held 60 shares of ALPS Medical Breakthroughs ETF worth $3 as of Q4 2025.
  • ALPS Medical Breakthroughs ETF was a new Motiv8 Investments position in Q4 2025.
  • ALPS Medical Breakthroughs ETF made up ﹤0.01% of Motiv8 Investments's portfolio in Q4 2025, its #696 holding.
  • 58 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.